Belite Bio (Belite Bio) ROE % Adjusted to Book Value : -2.84% (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Belite Bio ROE % Adjusted to Book Value?

Belite Bio's ROE % for the quarter that ended in Mar. 2024 was -33.69%. Belite Bio's PB Ratio for the quarter that ended in Mar. 2024 was 11.85. Belite Bio's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 was -2.84%.

Belite Bio ROE % Adjusted to Book Value Historical Data

The historical data trend for Belite Bio's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Belite Bio ROE % Adjusted to Book Value Chart

Belite Bio Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

-5.30

-3.25

Belite Bio Quarterly Data
	Dec20	Jun21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial							-3.40	-8.59	-4.84	-2.65	-2.84

Competitive Comparison of Belite Bio's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Belite Bio's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Belite Bio's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Belite Bio's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Belite Bio's ROE % Adjusted to Book Value falls into.

Belite Bio ROE % Adjusted to Book Value Calculation

Belite Bio's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-47.95%	/	14.75
	=	-3.25%

Belite Bio's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-33.69%	/	11.85
	=	-2.84%

Belite Bio ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Belite Bio's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Belite Bio (Belite Bio) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Belite Bio Inc (NAS:BLTE) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

D01:Germany

Address

12750 High Bluff Drive, Suite 475, San Diego, CA, USA, 92130

Website

https://www.belitebio.com

Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively lead to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.